欧洲银屑病与特应性皮炎患者的幸福感跨国横断面研究
本研究在八个欧洲国家的大学附属医院皮肤科开展横断面多中心调查,纳入723例银屑病和316例特应性皮炎成人患者,评估疾病相关生活质量、启发式幸福感、正负情绪与生活满意度。结果显示两病在幸福感、生活满意度和负性情绪上几乎无差异,但特应性皮炎患者DLQI及正性情绪受损更明显,且各国间存在显著差异,奥地利患者幸福感最高。
要点
- 特应性皮炎患者在DLQI和正性情绪上受损较银屑病患者更明显。
- 幸福感、生活满意度与负性情绪在银屑病与特应性皮炎间几乎无差异。
- 欧洲各国间DLQI、幸福感与生活满意度存在显著差异,需关注治疗可及性公平。
核心结论
- 研究显示欧洲各国间幸福感差异显著,特应性皮炎患者较银屑病患者受损更明显,提示需促进治疗可及性公平并开发针对性积极心理干预。
研究设计与样本
- 纳入成人银屑病(n=723)与特应性皮炎(n=316)患者,用母语填写标准化问卷,收集人口学、疾病特征、DLQI、启发式幸福感、正性情绪、负性情绪和生活满意度数据。
- 采用描述性分析与分位数回归。
主要发现
- 银屑病与特应性皮炎患者在幸福感、生活满意度和负性情绪上几乎无差异,仅DLQI和正性情绪存在小差异,特应性皮炎患者报告影响更大。
- DLQI、启发式幸福感、正性情绪、负性情绪和生活满意度存在国别差异,奥地利患者幸福感、满意度和积极性最高,同时治疗照护更高、疾病严重度更低。
- 分位数回归显示预测变量在不同分位数上系数不同,例如当前或既往接受系统治疗在不同分位数上与启发式幸福感呈正相关。
临床怎么用
- 提示皮肤科医生在评估银屑病和特应性皮炎时应关注患者幸福感与生活质量的国别差异及疾病差异。
- 结果支持推动治疗可及性公平,并考虑结合国别特点开展针对性积极心理干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dermatological research has traditionally concentrated on evaluating mental comorbidities, neglecting positive concepts like happiness. Initial studies indicate that psoriasis and atopic dermatitis (AD) impair the happiness of those affected. Considering global happiness variations, this study aimed to explore the disease- and country-specific differences in disease-related quality of life and happiness, and potential influential factors on heuristic happiness among psoriasis and AD patients in Europe. METHODS: A cross-sectional multicentre study was conducted in dermatology departments of university-affiliated hospitals in eight European countries (Austria, Germany, Italy, Malta, Poland, Portugal, Romania and Ukraine) between October 2021 and February 2023. Adult psoriasis and AD patients completed a standardized questionnaire in their native languages, providing data on demographics, disease-related characteristics, disease-related quality of life (Dermatology Life Quality Index, DLQI), heuristic happiness, positive affect (PA), negative affect (NA) and satisfaction with life (SWL). Descriptive analysis and quantile regression were performed. RESULTS: Between psoriasis (n = 723) and AD (n = 316) patients almost no differences were observed in happiness, SWL and NA, except for DLQI and small differences in PA, with AD patients reporting greater impact than psoriasis patients. Country-wise variation emerged in DLQI, heuristic happiness, PA, NA and SWL with Austrian patients displaying the highest levels of happiness, satisfaction and positivity, coupled with higher treatment care and lower disease severity. Quantile regression revealed varying coefficients for predictor variables across quantiles, indicating, for example positive effects on heuristic happiness associated with current or previous receipt of systemic therapies at different quantiles. CONCLUSIONS: This study shows notable happiness differences across European countries and significant disease-related variations, particularly with AD patients being more impaired than psoriasis patients. The findings highlight the need for equality in treatment access and support the development of targeted positive psychological interventions to enhance happiness considering country-specific distinctions in future research and health policies for psoriasis and AD patients.
引用
- Ziehfreund S, Wecker H, Mittag S, et al. Happiness across the borders-A cross-sectional study among patients with psoriasis and atopic dermatitis in Europe. J Eur Acad Dermatol Venereol. 2024. PMID: 39140310. doi:10.1111/jdv.20288
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。